Navigation Links
Grupo IMO Hosts Symposium on Use of TomoTherapy for Stereotactic Radiosurgery and Stereotactic Body Radiation Procedures : Experts Detail HiArt Platform Advantages for Treatment of Brain, Lung, Pancreatic and Metastatic Cancers
Date:10/15/2008

TomoTherapy Incorporated (NASDAQ: TOMO) announced today that Grupo IMO of Madrid, Spain, recently hosted a symposium on the clinical use of the HiArt treatment system for stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). Symposium speakers highlighted the HiArt system’s inherent suitability for stereotactic procedures with respect to dose conformality and homogeneity; presented clinical work on a variety of intra- and extracranial cases; and discussed future research goals.

MADISON, Wis. (Business Wire EON) October 15, 2008 -- According to Jef Van Dam, TomoTherapy EMEA General Manager: "We are extremely pleased that Grupo IMO hosted this symposium highlighting the excellent clinical stereotactic work being done by TomoTherapy customers. We are eager to demonstrate how the clinical applications of TomoTherapy continue to grow as new treatment possibilities are explored by our clinical partners."

The 'Symposium on Tomo-Radiosurgery' included presentations from Dr. Jos Sambls, neurosurgeon and Grupo IMO president, Dr. Jos Miguel Delgado, clinical physicist and technical director for Grupo IMO, and Dr. Matthias Uhl, radiation oncologist, Heidelberg University Clinic, Heidelberg, Germany. The event was held in conjunction with the Spanish Radiosurgery Conference.

Peter Hoban, Ph.D., TomoTherapy senior product managerand medical physicist, began the program by outlining features that make the HiArt system ideal for providing stereotactic treatments: "TomoTherapy's integrated imaging and delivery platform allows one simple process to be used for both stereotactic and intensity-modulated radiation therapy (IMRT) treatments. The system clearly lends itself to a diverse range of clinical indications, as evidenced by the presentations of Drs. Sambls, Delgado and Uhl."

  • Sambls and Dr. Delgado presented technical and clinical stereotactic work using the TomoTherapy HiArt treatment system and discussed Grupo IMO's research goals for the future.

Said Dr. Sambls: "TomoTherapy HiArt allows the development of new techniques for treating brain tumors with maximum precision. In this sense, we have achieved great preliminary results with what we call Tomo-Radiosurgery, fundamentally with regard to irregularly shaped brain tumors, brain metastases and tumors located close to critical organs such as the optic nerves and the brain stem. Another example is the treatment of acoustic neurinoma. We believe TomoTherapy's especially homogenous dose distribution capabilities may help to spare sensitive auditory nerve tissue."

  • Matthias Uhl explained how University Clinic Heidelberg has expanded its own use of the TomoTherapy HiArt system to include stereotactic treatments.

"We are applying TomoTherapy to SBRT for early-stage lung cancer and also multiple metastases in the brain and liver," said Dr. Uhl. "Treating multiple lesions simultaneously results in a reduced amount of timethe patient spends in the treatment room compared with conventional treatment alternatives."

About Grupo IMO

Grupo IMO is the first facility in Spain to offer TomoTherapy radiation treatments. More than 300 patients have been treated on the TomoTherapy HiArt System since April 2006. Established in 1991, Grupo IMO has the largest autonomous network of ten reference centers for cancer treatment using radiotherapy and radiosurgery techniques in Spain.

About TomoTherapy Incorporated

TomoTherapy Incorporated has developed, markets and sells the TomoTherapy HiArt treatment system, an advanced radiation therapy system for the treatment of a wide variety of cancers. The HiArt treatment system combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. The company's stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit TomoTherapy.com.

2008 TomoTherapy Incorporated. All rights reserved.TomoTherapy, the TomoTherapy logo and HiArt are among trademarks, service marks or registered trademarks of TomoTherapy Incorporated.

Read the full story at http://www.prweb.com/releases/grupo_imo/stereotactic_body/prweb1480034.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Grupo Casa Saba Announces Sales and Operating Income Increased 14.05% and 13.45%, Respectively
2. Grupo Casa Saba Announces Fourth Quarter 2007 Results
3. Grupo Casa Saba Announces Third Quarter 2007 Results
4. Pennsylvania Breast Cancer Coalition Hosts Annual Conference
5. Baird Hosts Small Cap Health Care Conference : Senior Healthcare Distribution & Services Research Analyst Eric Coldwell Shares Insights on Sector
6. Health Insurance Industry Hosts Roundtable Discussion on Health Care Reform in Albuquerque
7. RMA of Michigan Hosts 1st Metro Detroit Area Hope Uncorked: Exclusive Wine Tasting Event To Benefit Fertile Hope
8. Alameda County Hosts National Initiative to Reduce Health Disparities
9. Hospira Hosts Conference Call for Second-Quarter 2008 Earnings
10. National Medical Association Hosts the 2008 Annual Convention and Scientific Assembly
11. Bioniche Hosts Veterinarians and Food Industry Reps at Two-Day E. coli O157:H7 Vaccine Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 Grupo IMO Hosts Symposium on Use of TomoTherapy for Stereotactic Radiosurgery and Stereotactic Body Radiation Procedures :  Experts Detail HiArt Platform Advantages for Treatment of Brain, Lung, Pancreatic and Metastatic Cancers 
(Date:6/27/2016)... Viejo, California (PRWEB) , ... June 27, 2016 , ... ... are fully customizable inside of Final Cut Pro X," said Christina Austin - CEO ... another unique style. Final Cut Pro X users can now reveal the ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... strategic partnership with Connance, a healthcare industry leader providing predictive analytics to ... technology combine to provide health systems, hospitals and ambulatory surgical centers with ...
(Date:6/27/2016)... Overland Park, KS (PRWEB) , ... June 27, 2016 , ... ... leader in retailers of Eyeglasses . , Millions of individuals in the United ... life, eyeglasses have become a way to both correct vision and make a fashion ...
(Date:6/26/2016)... ... 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic ... World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. ... some of the world’s leading providers of cereal and other breakfast foods. Its residents ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/24/2016)... HILL, N.C. , June 24, 2016 /PRNewswire/ ... healthcare decisions and regulators/payers have placed more emphasis ... new environment, patient support programs in the pharmaceutical ... for patients, medications. Consequently, pharmaceutical companies are focusing ... ensure they are providing products and services that ...
(Date:6/24/2016)... CAMBRIDGE, Mass. , June 24, 2016 /PRNewswire/ ... the Spaulding Rehabilitation Network,s Dean Center for ... of Physical Medicine and Rehabilitation, MIT Hacking Medicine, ... Center for Innovation, today announced the five finalists ... Hackathon for Lyme disease.  More than 100 scientists, ...
Breaking Medicine Technology: